A 60 kd MDM2 isoform is produced by caspase cleavage in non-apoptotic tumor cells

被引:62
作者
Pochampally, R
Fodera, B
Chen, LH
Shao, WJ
Levine, EA
Chen, JD
机构
[1] Louisiana State Univ, Med Ctr, Dept Microbiol, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Med Ctr, Stanley S Scott Canc Ctr, Dept Surg, New Orleans, LA 70112 USA
关键词
MDM2; p53; oncogene; tumor suppressor; apoptosis; caspase; isoform;
D O I
10.1038/sj.onc.1202206
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The MDM2 oncogene product is a regulator of the p53 tumor suppressor. MDM2 is cleaved by Caspase 3 (CPP32) during apoptosis after aspartic acid-361, generating a 60 kd fragment. Here we report that human tumor cell lines often express high levels of a 60 kd MDM2 isoform (p60) in the absence of apoptosis. We demonstrate that p60 is a product of caspase cleavage of full length MDM2 after residue 361. The protease that cleaves MDM2 in non-apoptotic cells appears to be distinct from the apoptosis-specific Caspase 3, since Caspase 3 substrate poly(ADP-ribose) polymerase (PARP) is not cleaved in cells producing p60. The p60 form of MDM2 is a significant fraction of the p53-bound MDM2 protein in certain tumor cells, suggesting that it functions in the regulation of p53. p60 is also detected in breast tumors overexpressing MDM2. These observations suggest that MDM2 is regulated by caspase processing in non-apoptotic cells, and may account for the MDM2 proteins of similar mobility seen in tumors and other cell lines.
引用
收藏
页码:2629 / 2636
页数:8
相关论文
共 41 条
[1]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[2]   Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2 [J].
Blaydes, JP ;
Gire, V ;
Rowson, JM ;
WynfordThomas, D .
ONCOGENE, 1997, 14 (15) :1859-1868
[3]   Abnormal expression of MDM-2 in breast carcinomas [J].
BuesoRamos, CE ;
Manshouri, T ;
Haidar, MA ;
Yang, Y ;
McCown, P ;
Ordonez, N ;
Glassman, A ;
Sneige, N ;
Albitar, M .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (02) :179-188
[4]  
BUESORAMOS CE, 1993, BLOOD, V82, P2617
[5]   INTERACTIONS BETWEEN P53 AND MDM2 IN A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY [J].
CHEN, CY ;
OLINER, JD ;
ZHAN, QM ;
FORNACE, AJ ;
VOGELSTEIN, B ;
KASTAN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2684-2688
[6]   REGULATION OF TRANSCRIPTION FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR BY THE MDM-2 ONCOGENE [J].
CHEN, JD ;
LIN, JY ;
LEVINE, AJ .
MOLECULAR MEDICINE, 1995, 1 (02) :142-152
[7]  
Chen JD, 1996, MOL CELL BIOL, V16, P2445
[8]   MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS [J].
CHEN, JD ;
MARECHAL, V ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) :4107-4114
[9]   Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage [J].
Chen, LH ;
Agrawal, S ;
Zhou, WQ ;
Zhang, RW ;
Chen, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :195-200
[10]   Proteolytic cleavage of the mdm2 oncoprotein during apoptosis [J].
Chen, LH ;
Marechal, V ;
Moreau, J ;
Levine, AJ ;
Chen, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22966-22973